Hutchmed (China) Limited - American Depositary Shares (HCM) closed at $15.16 on November 6, 2026, up 6.8% from the previous close, on volume of 150,710 shares (30-day average 49,943).
Data as of November 6, 2026.
Citi Remains a Buy on HUTCHMED (China) (HCM)
TipRanks (Fri, 6-Nov 7:25 PM ET)
Globe Newswire (Thu, 5-Nov 8:35 AM ET)
At a glance: stocks gapping up premarket
Seeking Alpha News (Thu, 5-Nov 7:25 AM ET)
Globe Newswire (Wed, 4-Nov 7:00 PM ET)
Globe Newswire (Sun, 1-Nov 7:00 PM ET)
HUTCHMED (China) (HCM) Gets a Buy from Orient Securities
TipRanks (Sun, 1-Nov 5:36 PM ET)
Globe Newswire (Wed, 28-Oct 8:00 PM ET)
HUTCHMED Sets November 5 Webcast to Spotlight Phase III Savolitinib Data in MET-Driven NSCLC
Market Chameleon (Tue, 27-Oct 3:15 AM ET)
Globe Newswire (Mon, 26-Oct 8:00 PM ET)
Globe Newswire (Mon, 26-Oct 4:30 AM ET)
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
Hutchmed (China) Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol HCM.
As of November 6, 2026, HCM stock price climbed to $15.16 with 150,710 million shares trading.
HCM has a beta of 1.20, meaning it tends to be more sensitive to market movements. HCM has a correlation of 0.13 to the broad based SPY ETF.
HCM has a market cap of $2.64 billion. This is considered a Mid Cap stock.
In the last 3 years, HCM traded as high as $21.92 and as low as $9.77.
The top ETF exchange traded funds that HCM belongs to (by Net Assets): SPDW, DFEM, DFAX, DFSE.
HCM has underperformed the market in the last year with a return of -2.6%, while SPY returned +9.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HCM shares. However, HCM has outperformed the market in the last 3 month and 2 week periods, returning +31.3% and +6.2%, while SPY returned -4.2% and -3.8%, respectively. This indicates HCM has been having a stronger performance recently.
HCM support price is $13.79 and resistance is $14.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCM shares will trade within this expected range on the day.
